Clinical Trials In the News About Newsletter COVID-19 Newsletters The Pandemic Will End: How and Why May 3, 2020 In many ways we’ve been fortunate. Despite a pandemic, society has not broken down. Read More Alzheimer’s Patient Newsletter February 2020 February 6, 2020 Aducanumab, the first Alzheimer’s-modifying therapy, submitted to the FDA. Can Biogen recover from their errors? Read More MS Patient Newsletter December 2019 December 1, 2019 The field of MS research has had amazing success in the last two decades. Read More Alzheimer’s Patient Newsletter July 2019 July 10, 2019 One day, one of the trials in Alzheimer’s disease will be positive. We think this trial may already be underway. Read More
The Pandemic Will End: How and Why May 3, 2020 In many ways we’ve been fortunate. Despite a pandemic, society has not broken down. Read More
Alzheimer’s Patient Newsletter February 2020 February 6, 2020 Aducanumab, the first Alzheimer’s-modifying therapy, submitted to the FDA. Can Biogen recover from their errors? Read More
MS Patient Newsletter December 2019 December 1, 2019 The field of MS research has had amazing success in the last two decades. Read More
Alzheimer’s Patient Newsletter July 2019 July 10, 2019 One day, one of the trials in Alzheimer’s disease will be positive. We think this trial may already be underway. Read More